Literature DB >> 11423119

Requirements of basic amino acid residues within the lectin-like domain of LOX-1 for the binding of oxidized low-density lipoprotein.

M Chen1, K Inoue, S Narumiya, T Masaki, T Sawamura.   

Abstract

Lectin-like OxLDL receptor-1 (LOX-1) was identified as the major receptor for oxidized low-density lipoprotein (OxLDL) in aortic endothelial cells. LOX-1 is a type II membrane protein that structurally belongs to the C-type lectin family. Here, we found that the lectin-like domain of LOX-1 is essential for ligand binding, but the neck domain is not. In particular, the large loop between the third and fourth cysteine of the lectin-like domain plays a critical role for OxLDL binding as well as C-terminal end residues. Alanine-directed mutagenesis of the basic amino acid residues around this region revealed that all of the basic residues are involved in OxLDL binding. Simultaneous mutations of these basic residues almost abolished the OxLDL-binding activity of LOX-1. Electrostatic interaction between basic residues in the lectin-like domain of LOX-1 and negatively charged OxLDL is critical for the binding activity of LOX-1.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11423119     DOI: 10.1016/s0014-5793(01)02557-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis.

Authors:  Mehmet Cilingiroglu; Kerem Ozer
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

Review 2.  Mechanisms of foam cell formation in atherosclerosis.

Authors:  Dimitry A Chistiakov; Alexandra A Melnichenko; Veronika A Myasoedova; Andrey V Grechko; Alexander N Orekhov
Journal:  J Mol Med (Berl)       Date:  2017-08-07       Impact factor: 4.599

3.  Serum amyloid A self-assembles with phospholipids to form stable protein-rich nanoparticles with a distinct structure: A hypothetical function of SAA as a "molecular mop" in immune response.

Authors:  Nicholas M Frame; Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  J Struct Biol       Date:  2017-06-20       Impact factor: 2.867

4.  Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation.

Authors:  Megumi Honjo; Kayo Nakamura; Kenji Yamashiro; Junichi Kiryu; Hidenobu Tanihara; Leslie M McEvoy; Yoshihito Honda; Eugene C Butcher; Tomoh Masaki; Tatsuya Sawamura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

5.  Lectin-like Ox-LDL receptor is expressed in human INT-407 intestinal cells: involvement in the transcytosis of pancreatic bile salt-dependent lipase.

Authors:  Nadine Bruneau; Stéphane Richard; Françoise Silvy; Alain Verine; Dominique Lombardo
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

6.  Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1) gene is associated with plasma soluble LOX-1 levels.

Authors:  Tina E Brinkley; Noriaki Kume; Hirokazu Mitsuoka; Michael D Brown; Dana A Phares; Robert E Ferrell; Toru Kita; James M Hagberg
Journal:  Exp Physiol       Date:  2008-05-09       Impact factor: 2.969

7.  Generation and characterization of chicken monoclonal antibodies against human LOX-1.

Authors:  Shin Iwamoto; Norihisa Nishimichi; Yoshiko Tateishi; Yuko Sato; Hiroyuki Horiuchi; Shuichi Furusawa; Tatsuya Sawamura; Haruo Matsuda
Journal:  MAbs       Date:  2009 Jul-Aug       Impact factor: 5.857

8.  Mapping and characterization of the binding site for specific oxidized phospholipids and oxidized low density lipoprotein of scavenger receptor CD36.

Authors:  Niladri S Kar; Mohammad Z Ashraf; Manojkumar Valiyaveettil; Eugene A Podrez
Journal:  J Biol Chem       Date:  2008-02-01       Impact factor: 5.157

9.  LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells.

Authors:  Jane E Murphy; Daryl Tacon; Philip R Tedbury; Jonathan M Hadden; Stuart Knowling; Tatsuya Sawamura; Michelle Peckham; Simon E V Phillips; John H Walker; Sreenivasan Ponnambalam
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

10.  Molecular dynamics simulation of human LOX-1 provides an explanation for the lack of OxLDL binding to the Trp150Ala mutant.

Authors:  Mattia Falconi; Silvia Biocca; Giuseppe Novelli; Alessandro Desideri
Journal:  BMC Struct Biol       Date:  2007-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.